CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Stockholders’ (Deficit) Equity	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Treasury stock, at cost	Non-controlling interest
Balance at Dec. 31, 2022	$ 103,864	$ 100,017	$ 12	$ 787,130	$ (688,492)	$ 1,371	$ (4)	$ 3,847
Balance (in Shares) at Dec. 31, 2022			106,417,265
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of RSUs (in shares)			619,387
Issuance of RSAs (in shares)			27,744
Exercise of common stock options	25	25		25
Exercise of common stock options (in Shares)			91,258
Stock-based compensation expense	4,548	4,548		4,548
Net loss	(16,349)	(16,349)			(16,349)
Foreign currency translation adjustment	432	432				432
Balance at Mar. 31, 2023	92,520	88,673	$ 12	791,703	(704,841)	1,803	(4)	3,847
Balance (in Shares) at Mar. 31, 2023			107,155,654
Balance at Dec. 31, 2023	80,096	78,734	$ 12	837,416	(760,227)	2,198	(665)	1,362
Balance (in Shares) at Dec. 31, 2023			111,132,222
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of RSUs (in shares)			1,226,498
Issuance of RSAs (in shares)			38,130
Exercise of common stock options	544	544		544
Exercise of common stock options (in Shares)			186,074
Reclassification of warrant liability to Common Stock warrants	2,468	2,468		2,468
Stock-based compensation expense	6,293	6,293		6,293
Net loss	(31,610)	(31,610)			(31,610)
Foreign currency translation adjustment	(522)	(522)				(522)
Balance at Mar. 31, 2024	$ 57,269	$ 55,907	$ 12	$ 846,721	$ (791,837)	$ 1,676	$ (665)	$ 1,362
Balance (in Shares) at Mar. 31, 2024			112,582,924